<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01829347</url>
  </required_header>
  <id_info>
    <org_study_id>VTI-210</org_study_id>
    <nct_id>NCT01829347</nct_id>
  </id_info>
  <brief_title>Study to Assess Safety and Efficacy of ELAD in Subjects With Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure</brief_title>
  <official_title>A Randomized, Open-Label, Multicenter, Controlled Study to Assess Safety and Efficacy of ELAD® in Subjects With Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vital Therapies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vital Therapies, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if treatment with the ELAD System is safe and
      effective in subjects with severe acute alcoholic hepatitis and Lille score failures (Lille
      score &gt;0.45).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Lille score will be used to identify subjects with an increased risk of mortality (Lille
      score failures). The Lille score is a prognostic model combining six reproducible variables
      at Day 0 and Day 7 of steroid treatment. The Lille score used in this protocol is being used
      independent of steroid administration during the 7 days of evaluation. A Lille score &gt;0.45
      (Lille score failure) indicates that the subject is at substantially increased risk of 30-
      and 90-day mortality. Subjects with severe acute alcoholic hepatitis (sAAH) are often treated
      with steroids as soon as their diagnosis is confirmed. This study is to assess treatment with
      the ELAD System in subjects who have failed per the Lille criteria, independent of steroid
      administration. ELAD treatment is done continuously for up to 10 days in addition to standard
      of care treatment. The Control group (those randomized not to receive ELAD treatment) will
      also get standard of care treatment. Standard of care is defined as the usual care for diet,
      medications, treatment of complications that may arise, etc. for sAAH patients.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to results from the 1st pivotal study, the ELAD clinical plan is being re-evaluated, and
    the VTI-210 study has been terminated.
  </why_stopped>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival of sAAH subjects</measure>
    <time_frame>Study Day 1 through Study Day 91</time_frame>
    <description>The primary objective of the study is to evaluate safety and efficacy of ELAD with respect to overall survival (OS) in subjects with a clinical diagnosis of severe acute alcoholic hepatitis (sAAH) who are Lille score failures (Lille score &gt;0.45).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the proportion of survivors at End of Study Days 28 and 91.</measure>
    <time_frame>Study Days 28 and 91.</time_frame>
    <description>A chi-square test will be used to evaluate the proportion of subjects who survived at End of Study Day 28 and End of Study Day 91 based on the ITT population.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Severe Acute Alcoholic Hepatitis</condition>
  <arm_group>
    <arm_group_label>ELAD (plus Standard of Care)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ELAD is a human cell-based bio-artificial liver support system developed to improve survival of patients with acute liver failure and to provide liver support continuously to a subject with compromised liver function. Standard of care is predefined treatment for sAAH complications (ascites, hepatic encephalopathy, varices, etc.) per AASLD/EASL Guidelines.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care (Control)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard of care is predefined treatment for sAAH complications (ascites, hepatic encephalopathy, varices, etc.) per AASLD.EASL Guidelines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ELAD</intervention_name>
    <description>ELAD is an extracorporeal system that draws blood from the subject via a dual-lumen catheter placed in a large vein, and then separates the plasma fluid (ultrafiltrate) from cellular components using a specifically-designed ultrafiltrate generator cartridge. While the cellular components are returned to the subject via the venous access, the ultrafiltrate is circulated at a high flow rate through the four metabolically-active ELAD cartridges which contain cloned, immortalized human hepatoblastoma cells (VTL C3A cells) derived from a subclone of the human hepatoblastoma cell line HepG2.</description>
    <arm_group_label>ELAD (plus Standard of Care)</arm_group_label>
    <other_name>Human Cell-Based Bio-Artificial Liver Support System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care treatment</intervention_name>
    <description>Standard of care is predefined treatment for sAAH complications (ascites, hepatic encephalopathy, varices, etc.)</description>
    <arm_group_label>ELAD (plus Standard of Care)</arm_group_label>
    <arm_group_label>Standard of Care (Control)</arm_group_label>
    <other_name>Usual treatment for the disease</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 ;

          -  Total bilirubin ≥8 mg/dL;

          -  Medical history of alcohol abuse with evidence of a causal and temporal (&lt;6 weeks)
             relationship to the use of alcohol and hospital admission for this episode of sAAH;

          -  Maddrey score ≥32

          -  A clinical diagnosis of severe acute alcoholic hepatitis (sAAH);

          -  Subject must have liver biopsy or in investigator's opinion, if risk is too great to
             perform liver biopsy, then clinical diagnosis is sufficient;

          -  Subject must be a Lille score failure (Lille score &gt;0.45) as defined in this study.

        Exclusion Criteria:

          -  Platelet count &lt;50,000/mm3;

          -  International Normalization Ratio (INR) &gt;3.0;

          -  MELD score &gt;35;

          -  Evidence of infection unresponsive to antibiotics;

          -  Evidence of jaundice for &gt;3 months;

          -  Hospital admission for any episodes of liver decompensation not related to sAAH,
             (other than this episode of sAAH) within the past 2 months;

          -  Evidence of hemodynamic instability;

          -  Evidence of active bleeding or of major hemorrhage defined as requiring ≥2 units of
             packed red blood cells to maintain a stable hemoglobin occurring within 48 hours of
             Screening;

          -  Evidence of occlusive portal vein thrombosis impairing hepatopetal flow, or evidence
             of bile duct obstruction;

          -  Evidence by physical exam, history, or laboratory evaluation of significant
             concomitant disease with expected life expectancy of less than 3 months;

          -  Clinical evidence of liver size reduction due to cirrhosis, unless Investigator
             interpretation of the clinical evidence indicates liver size of &lt;10 cm or volume of
             &lt;750 cc is not considered reduced for the individual subject;

          -  Chronic end-stage renal disease requiring chronic hemodialysis for more than 8 weeks
             (not classified as hepatorenal syndrome);

          -  Uncontrolled seizures;

          -  Positive serologies for viral hepatitis B or C;

          -  Pregnancy as determined by β-human chorionic gonadotropin (HCG) results;

          -  Participation in another investigational drug, biologic, or device study within one
             month of enrollment, except for observational studies (the observational study setting
             should not affect the safety and/or efficacy of the VTI-210 clinical trial);

          -  Currently listed or scheduled for liver transplant during the 90-day study period;

          -  Previous liver transplant;

          -  Previous participation in a clinical trial involving ELAD;

          -  Has a Do Not Resuscitate or a Do Not Intubate (DNR/DNI) directive (or local
             equivalent) or any other Advanced Directive limiting Standard of Care in place (the
             DNR/DNI criterion is not applicable in the UK);

          -  Refusal to participate in the VTI-210E follow-up study;

          -  Is unable to provide an address for follow-up home visits.

        And other inclusion/exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Stange, MD</last_name>
    <role>Study Director</role>
    <affiliation>Vital Therapies, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rajiv Jalan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UK - Royal Free Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Caballeria, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Clinic de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José Luis Montero, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Reina Sofia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rafael Bañares, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Gregorio Marañon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kalyan R Bhamidimarri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>FL - University of Miami Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julie Thompson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MN - University of Minnesota Medical Center - Twin Cities Campus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valentin Cuervas-Mons Martinez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario Puerta de Hierro - Majadahonda</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Santiago Tome, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Clinico Universitario de Santiago de Compostela</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martín Prieto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario y Politécnico La Fe</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sumita Verma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UK - Brighton &amp; Sussex University Hospitals NHS Trust</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul J Gaglio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NY - Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Romero-Gomez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario de Valme</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew deLemos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NC - Carolinas Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joanna Sayer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UK - Doncaster Royal Infirmary</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lance Stein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GA - Piedmont Atlanta Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javier Crespo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario Marques de Valdecilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rohit Satoskar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>DC - Georgetown University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David J Kramer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WI - Aurora St. Luke's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Reich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PA - Drexel University College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne M Larson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WA - Swedish Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xaralambos Zervos, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>FL - Cleveland Clinic Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kirti Shetty, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD - Johns Hopkins University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simona Rossi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PA - Albert Einstein Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ram Subramanian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GA - Emory University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Kuo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CA - University of California San Diego</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Talal Adhami, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OH - Cleveland Clinic Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Jesús Suárez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario de Cruces</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nikolaos T Pyrsopoulos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NJ - Rutgers University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julio Gutierrez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TX - University of Texas Health Science Center, San Antonio</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andres Duarte-Rojo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AR - University of Arkansas for Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Agustín Albillos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario Ramón y Cajal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raza Malik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MA - Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Busch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germany - Medizinische Hochschule Hannover</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anupama Duddempudi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NY - North Shore University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Antonio Olivera-Martinez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NE - University of Nebraska Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eckart Schott, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germany - Charité Campus Virchow-Klinikum Medizinische Klinik</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Atlanta Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University Hospital</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center - Twin Cities Campus</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rutgers University Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drexel University College of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Einstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center, San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Campus Virchow-Klinikum Medizinische Klinik</name>
      <address>
        <city>Berlin</city>
        <zip>D-13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>D-30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>La Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro - Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28220</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Cruces</name>
      <address>
        <city>San Vicente de Barakaldo</city>
        <state>Vizcaya</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Reina Sofia</name>
      <address>
        <city>Cordoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marques de Valdecilla</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Valme</name>
      <address>
        <city>Sevilla</city>
        <zip>41014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brighton &amp; Sussex University Hospitals NHS Trust</name>
      <address>
        <city>Eastern Road</city>
        <state>Brighton</state>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barts Health NHS Trust</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College Hospital NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>SE59RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>Hampstead</city>
        <state>London</state>
        <zip>NW3 2QR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NHS Tayside</name>
      <address>
        <city>Dundee</city>
        <state>Scotland</state>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doncaster Royal Infirmary</name>
      <address>
        <city>Doncaster</city>
        <state>South Yorkshire</state>
        <zip>DN2 5LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.vitaltherapies.com</url>
  </link>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2013</study_first_submitted>
  <study_first_submitted_qc>April 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2013</study_first_posted>
  <last_update_submitted>October 20, 2015</last_update_submitted>
  <last_update_submitted_qc>October 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver failure</keyword>
  <keyword>acute alcoholic hepatitis</keyword>
  <keyword>patients failing steroid therapy</keyword>
  <keyword>alcoholic hepatitis</keyword>
  <keyword>steroid failure</keyword>
  <keyword>Lille criteria</keyword>
  <keyword>ELAD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis, Alcoholic</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>May 15, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

